Use of a focal immunofluorescence assay on live cells for quantitation of retroviruses: distinction of host range classes in virus mixtures and biological cloning of dual-tropic murine leukemia viruses.
about
A crucial role for infected-cell/antibody immune complexes in the enhancement of endogenous antiviral immunity by short passive immunotherapyProtection against retrovirus pathogenesis by SR protein inhibitors.Lipopolysaccharide restores anti-Candida albicans growth inhibition activity of polymorphonuclear neutrophils from retrovirus-immunosuppressed miceVaccination with an adenoviral vector that encodes and displays a retroviral antigen induces improved neutralizing antibody and CD4+ T-cell responses and confers enhanced protection.The fusion-controlling disulfide bond isomerase in retrovirus Env is triggered by protein destabilization.Precise identification of endogenous proviruses of NFS/N mice participating in recombination with moloney ecotropic murine leukemia virus (MuLV) to generate polytropic MuLVs.Incorporation of mouse APOBEC3 into murine leukemia virus virions decreases the activity and fidelity of reverse transcriptase.Characterization of a live-attenuated retroviral vaccine demonstrates protection via immune mechanisms.A novel subgenomic murine leukemia virus RNA transcript results from alternative splicing.Sequences between the enhancer and promoter in the long terminal repeat affect murine leukemia virus pathogenicity and replication in the thymus.Appearance of mink cell focus-inducing recombinants during in vivo infection by moloney murine leukemia virus (M-MuLV) or the Mo+PyF101 M-MuLV enhancer variant: implications for sites of generation and roles in leukemogenesisKinetics of the development of protective immunity in mice vaccinated with a live attenuated retrovirus.Genetic regulation of long-term nonprogression in E-55+ murine leukemia virus infection in miceIntroduction of a cis-acting mutation in the capsid-coding gene of moloney murine leukemia virus extends its leukemogenic propertiesCD4(+) T cells and gamma interferon in the long-term control of persistent friend retrovirus infection.Role of interleukin-4 (IL-4), IL-12, and gamma interferon in primary and vaccine-primed immune responses to Friend retrovirus infectionThe glycosylated Gag protein of a murine leukemia virus inhibits the antiretroviral function of APOBEC3.In vivo interactions of ecotropic and polytropic murine leukemia viruses in mixed retrovirus infections.Interleukin-encoding adenoviral vectors as genetic adjuvant for vaccination against retroviral infectionEfficient mother-to-child transfer of antiretroviral immunity in the context of preclinical monoclonal antibody-based immunotherapyImproved vaccine protection against retrovirus infection after co-administration of adenoviral vectors encoding viral antigens and type I interferon subtypesCodelivery of the chemokine CCL3 by an adenovirus-based vaccine improves protection from retrovirus infection.Infection of central nervous system cells by ecotropic murine leukemia virus in C58 and AKR mice and in in utero-infected CE/J mice predisposes mice to paralytic infection by lactate dehydrogenase-elevating virus.Rabies virus replication in primary murine bone marrow macrophages and in human and murine macrophage-like cell lines: implications for viral persistenceIsolation of new oncogenic forms of the murine c-fms gene.Inhibitory effect of nitric oxide on the replication of a murine retrovirus in vitro and in vivo.Characterization of a neurologic disease induced by a polytropic murine retrovirus: evidence for differential targeting of ecotropic and polytropic viruses in the brainA multistep process of leukemogenesis in Moloney murine leukemia virus-infected mice that is modulated by retroviral pseudotyping and interference.Neurologic disease induced by polytropic murine retroviruses: neurovirulence determined by efficiency of spread to microglial cellsA small region of the ecotropic murine leukemia virus (MuLV) gag gene profoundly influences the types of polytropic MuLVs generated in mice.Profound amplification of pathogenic murine polytropic retrovirus release from coinfected cellsInfluence of the murine MHC (H-2) on Friend leukemia virus-induced immunosuppression.Pathogenesis of arteritis of SL/Ni mice. Possible lytic effect of anti-gp70 antibodies on vascular smooth muscle cells.The endogenous mink cell focus-forming (MCF) gp70 linked to the Rmcf gene restricts MCF virus replication in vivo and provides partial resistance to erythroleukemia induced by Friend murine leukemia virus.Genetic control of T cell responsiveness to the Friend murine leukemia virus envelope antigen. Identification of class II loci of the H-2 as immune response genesMonoclonal antibody 667 recognizes the variable region A motif of the ecotropic retrovirus CasBrE envelope glycoprotein and inhibits Env binding to the viral receptor.Expression of infectious murine leukemia viruses by RAW264.7 cells, a potential complication for studies with a widely used mouse macrophage cell line.Different abilities of Friend murine leukemia virus (MuLV) and Moloney MuLV to induce promonocytic leukemia are due to determinants in both psi-gag-PR and env regions.Characterization of epitopes defining two major subclasses of polytropic murine leukemia viruses (MuLVs) which are differentially expressed in mice infected with different ecotropic MuLVsA nonstructural gag-encoded glycoprotein precursor is necessary for efficient spreading and pathogenesis of murine leukemia viruses
P2860
Q27314576-83FC2887-39CC-48C9-B1D9-A6C73BC5B3CBQ33410271-36767ED3-B4C0-4EEE-904A-BC2D760BC76CQ33597964-0CD90FA0-B348-41B1-977A-1DD0C77743A8Q33614622-0F50F4D2-3C50-4213-BC89-4B0D58BD760BQ33717680-21897015-922E-4DA1-8D4A-14549607199DQ33724241-E793533D-4CF3-4F83-8908-8FF83616F743Q33744029-29A72A5A-0F00-441B-87A5-CD1D306E74D5Q33783464-0B2B15E5-5C97-45EC-AD77-94CA7475E559Q33802491-492EEEBE-5FC5-484B-B722-EE3EE70332E2Q33814017-085BFE23-AC94-4015-B4F3-CF95C50B7B34Q33815467-239E8CD3-2169-4B36-AB27-345C30AC1012Q33820285-80AC7ADF-61E1-4864-87ED-7534C3437FF8Q33822962-C68540F2-8807-430E-AD25-901C505FF618Q33825632-A80FFCF1-5207-443F-BB5D-9139D8FA6395Q33834466-EA765026-B728-4B91-A4C4-90D38EDBD86CQ33835324-E9C6F58D-6D33-4843-8C12-20589308BBFCQ34178169-315FB080-AD2F-42B7-A2DA-FF1A5EE75D1CQ34647910-1FD95E9E-B1AB-4E5A-BACA-6247AD9C48EDQ35070346-495DB61B-4786-489E-AF3F-85BB73515CFEQ35101489-0705A071-BED6-4549-A199-18BA1A43B077Q35353052-BEE5B913-441C-4EF3-93AB-AE3427FFB3C6Q35689651-5EA2E979-4F75-4682-83E3-266EEC2BBDF6Q35829706-48176597-6CA0-4472-A279-DB49C4F85909Q35831354-8F0FB7AC-281D-407A-89E0-26F4A24CC539Q35839807-72284048-1BC7-4D75-900C-87857E16F3F5Q35850897-01C36E64-3E91-4C76-9405-9FFF56601F8DQ35852738-7E543D8A-372D-4DD1-B8EA-43E7D047783CQ35861712-B71D2B6A-F994-457A-AFB0-3ECD84E46078Q35888241-20E6B045-C464-4238-AD10-CB5AFB67F7AAQ35899379-DDBBD536-9EF7-49A0-99F7-4AA29B407751Q36155489-E4A4708B-66A9-4770-83B7-1853BB9229BBQ36351580-6AF54C77-BC95-46A5-9DED-D5CAC2A7860AQ36353949-EE2C9167-E122-49F2-8714-3E89CE89B46BQ36355008-D9863BEE-F6DB-498E-B4CE-C14C19CCEFC3Q36355568-9EA013C6-7F29-46D2-A06C-6FCB52DDBBB5Q36473595-0E44C1B6-A4EC-49AA-A806-B718C51C74F3Q36477179-8CCD9ADC-BBE1-460B-A533-22EC493F0029Q36625226-060F86AD-22E9-49D7-B3D1-F0B7AE30EE26Q36625616-B536030D-A61C-404F-960C-2E0770B8DADFQ36634291-F7281444-B4B9-40A3-A094-98D297E977DA
P2860
Use of a focal immunofluorescence assay on live cells for quantitation of retroviruses: distinction of host range classes in virus mixtures and biological cloning of dual-tropic murine leukemia viruses.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
1985年论文
@zh
1985年论文
@zh-cn
name
Use of a focal immunofluoresce ...... ropic murine leukemia viruses.
@en
Use of a focal immunofluoresce ...... ropic murine leukemia viruses.
@nl
type
label
Use of a focal immunofluoresce ...... ropic murine leukemia viruses.
@en
Use of a focal immunofluoresce ...... ropic murine leukemia viruses.
@nl
prefLabel
Use of a focal immunofluoresce ...... ropic murine leukemia viruses.
@en
Use of a focal immunofluoresce ...... ropic murine leukemia viruses.
@nl
P2093
P1433
P1476
Use of a focal immunofluoresce ...... ropic murine leukemia viruses.
@en
P2093
P304
P356
10.1016/0042-6822(85)90187-4
P407
P577
1985-02-01T00:00:00Z